| Type | Title | Date Released | |
|---|---|---|---|
8-K | Larimar Therapeutics Completes Rolling BLA Submission for Nomlabofusp in Friedreich’s Ataxia New | ||
4 | Harlow John B. Jr. (Reporting) | ||
3 | Harlow John B. Jr. (Reporting) | ||
8-K | Larimar Therapeutics Appoints John B. Harlow, Jr. as President and Chief Operating Officer | ||
10-Q | Form 10-Q | ||
8-K | Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update | ||
4 | Hamilton Thomas Edward (Reporting) | ||
8-K | Larimar Therapeutics Submits First Module of Rolling BLA for Nomlabofusp and Reports Positive Long-Term Data in Friedreich’s Ataxia | ||
4 | DEERFIELD MANAGEMENT COMPANY, L.P. (Reporting) | ||
4 | LEFF JONATHAN S (Reporting) | ||
4 | SHERMAN JEFFREY W (Reporting) | ||
4 | Truitt Joseph (Reporting) |
